www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products placed in pre-open pending acquisition announcement
Healthcare group Stirling Products (ASX:STI) requested a trading half from the ASX today, pending an acquisition.
Stirling stated, '... pending an announcement by the Company in relation to the acquisition of a rapidly growing pathology business with current revenues of approximately $7,500,000.'


















